Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Number: NCT03007732 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Lawrence Fong|Prostate Cancer Foundation|Merck Sharp & Dohme Corp.|Dynavax Technologies Corporation|University of California, San Francisco Sponsor Trial Information Trial Location(s) and Contact(s)